DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

The Westin Boston Seaport District

2025年3月10日 (月) 午前 8:00 - 2025年3月12日 (水) 午後 12:30

425 Summer Street, Boston, MA 02210, USA

Medical Affairs and Scientific Communications Forum

The longest running neutral forum cultivating interdepartmental relationships in medical affairs.

Session 4: Plenary Session: Reimagining the World of Medical Writing, MedCom, and Field Medical: AI/GenAI as the Game Changers

Session Chair(s)

Nimita  Limaye, PhD

Nimita Limaye, PhD

Research VP, Life Sciences R&D Strategy and Technology, at IDC

IDC, United States

Sarah  Jarvis, MBA

Sarah Jarvis, MBA

Global Medical & Evidence Lead

ZS Associates, United States

This session will discuss how technology players, CROs, and life sciences companies are leveraging AI/GenAI to transform Medical Writing, MedCom, and Field Medical operations. It will dig into some of the implementation challenges, the AI identity threat, change management, key strategies for driving success, and the outcomes achieved.

Learning Objective :
  • Identify ways to address challenges in trying to embed AI/GenAI in Medical Writing, MedCom, and Field Medical operations
  • Recognize the AI identity threat and how to address the threat
  • Identify key strategies for driving success and outcomes achieved

Speaker(s)

Sidd  Bhattacharya, MBA

Speaker

Sidd Bhattacharya, MBA

PwC, United States

Partner, Generative AI Leader, Pharma and Life-Sciences

Donna A. Holder, PharmD

Speaker

Donna A. Holder, PharmD

Daiichi Sankyo, Inc., United States

Executive Director, Head of Digital Strategy and Innovation

Woo  Song

Speaker

Woo Song

Xogene, United States

CEO

Jennifer  Ghith, MBA, MS

Speaker

Jennifer Ghith, MBA, MS

GlaxoSmithKline, United States

Senior Director, Channel Integration and Innovation Lead, Global Scientific Comm

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。